Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 14, 2022
Product Development

Poxvirus agents, by the mechanisms

The mechanisms of products approved for monkeypox and other orthopoxviruses offer the potential for combinations
BioCentury | Aug 8, 2018
Distillery Therapeutics

Neurology

BioCentury | Feb 8, 2018
Company News

FDA approves Gilead's triple combo HIV therapy

BioCentury | Jan 23, 2018
Distillery Techniques

Drug delivery

BioCentury | Jul 31, 2017
Distillery Techniques

Disease models

BioCentury | Jun 16, 2017
Clinical News

Gilead submits NDA for HIV triple therapy

BioCentury | Apr 28, 2017
Clinical News

Tenofovir exalidex: Interim Ph IIa data

BioCentury | Jan 3, 2017
Distillery Therapeutics

Infectious disease

BioCentury | Nov 18, 2013
Clinical News

Clevudine regulatory update

BioCentury | Dec 3, 2009
Cover Story

Transcription prescription for herpes

Items per page:
1 - 10 of 23